After months of volatility and uncertainty in the crypto market, it's time to get back to the basics. Instead of chasing losses or doubling down on underperforming investments, it's time to focus on ...

One of them is CRISPR Therapeutics ( CRSP -0.90%). It has an approved gene-editing therapy, but investors haven't been buying ...